THE OPIOID SYSTEM AND ITS POSSIBLE ROLE IN ADAPTATION TO HYPOXIA
The present article reviews the role of opioid receptors and their endogenous and synthetic agonists in the formation of resistance to the action of condition of acute hypoxia. It shows that stimulation of opioid receptors is accompanied by a neuroprotective effect in acute hypoxia. It examines the role of different types of opioid receptors in the implementation of the protective effect of adaptation to hypoxia. The authors analyzed the results on the mechanisms of action of opioids, the role of cAMP, cGMP, nitric oxide, inositol triphosphate, K+- and Ca2+-channels in realization of the effects of agonists of opioid receptors. It discussed opioidergic mechanisms of the reactions that increase the resistance to hypoxia.
Keywords: opioid receptors, opioid system, КАТР-channels, cAMP, cGMP, inositoltriphosphate, nitric oxide, hypoxia, adaptation
References:
1. Kudrya O. Features urgent adaptation of the cardiovascular system of athletes with different vegetative tonus in orthostatic testing. Tomsk State Pedagogical University Bulletin, 2011, no. 5 (107), pp. 55–61 (in Russian).
2. Dhawan B. N., Cesselin F., Raghubir R. International union of pharmacology. XII. Classifi cation of opioid receptors. Pharmacol. Rev., 1996, vol. 48, no. 4, pp. 567–592.
3. Levac B. A., O'Dowd B. F., George S. R. Oligomerization of opioid receptors: generation of novel signaling units. Curr. Opin. Pharmacol., 2002. vol. 2, no. 1, pp. 76–81.
4. Minami M. Molecular biology of the opioid receptors: Structures functions and distributions. Neurosci Res., 1995, vol. 23, pp. 121–145.
5. Brown D. R. Delta-opioid receptor mRNA еxpression and immunogistochemical localization in porcine ileum. Dig. Dis. Sci., 1998, vol. 43, pp. 1402–1410.
6. Ventura C., Guarnieri C., Vaona I. Dynorphin gene expression and release in the myocardial cell. J. Biol. Chem., 1994, vol. 269, no. 7, pp. 5384–5386.
7. Maslov L. N., Lishmanov Y .B. Changes in opioid peptide level in the heart and blood plasma during acute myocardial ischaemia complicated by ventricular fi brillation. Clin. Exp. Pharm. Physiol., 1995, vol. 22, pp. 812–816.
8. Ventura C., Spurgeon H. A., Lоkatta E. G. k and d opioid receptor stimulation affects cardiac myocyte function and Ca2+ release from an intacellular pool in myocytes and neurons. Circ. Res., 1992, vol. 70, pp. 66–81.
9. Cadet P., Bilfi nger T. V., Fimiani C. Human vascular and cardiac endothelia express mu opiate receptor transcripts. Endothelium, 2000, no. 7, pp. 185–191.
10. Wittert G., Hope P., Pyle D. Tissue distribution of opioid receptor gene expression in the rat. Biochem. Biophys. Res. Commun., 1996, vol. 218, pp. 877–881.
11. Eguchi M. Recent advances in selective opioid receptor agonists and antagonists. Medical Research Rev., 2004, vol. 24, no. 2, pp. 182–212.
12. Law P. Y., Loh H. H. Regulation of opioid receptor activities. J. Pharmacol. Exp. Ther., 1999, vol. 289, no. 2, pp. 607–624.
13. Lasukova T.V., Maslov L.N., Gorbunov S. Opioid receptor agonists mimic the phenomenon of "ischemic preconditioning" of the heart: the role of cyclic nucleotides and Ca2+-ATPase of sarcoplasmic reticulum. Tomsk State Pedagogical University Bulletin, 2010, no. 3 (93). pp. 64–69 (in Russian).
14. Niroomand F., Mura R. A., Piacentini L. Opioid receptor agonists activate pertussis toxin-sensitive G proteins and inhibit adenylyl cyclase in canine cardiac sarcolemma.Arch. Pharmacol., 1996, vol. 354, pp. 643–649.
15. Maslov L. N., Lishmanov Yu. B. The anti-arrhythmic effect of D-Ala2, Leu5, Arg6-enkephalin and its possible mechanism. Int. J. Cardiol., 1993, vol. 40, no. 2, pp. 89–94.
16. Gross R. A., Moises H. C., Uhler M. D. Dynorphin A and cAMP-dependent protein kinase independently regulate calcium currents. Proc. Natl. Acad. Sci. USA, 1990, vol. 87, pp. 7025–7029.
17. Gross G. J., Fryer R. M. Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning. Circ. Res., 1999, vol. 84, pp. 973–979.
18. Shankar V., Armstead W. M. Opioids contribute to hypoxia-induced pial artery dilation throgh activation of ATP-sensitive K+ channels. Am. J. Physiol., 1995, vol. 269, pp. 997–1002.
19. Stefano G. B., Goumon Y., Bilfi nger T. V. Basal nitric oxide limits immune, nervous and cardiovascular excitation: Human endothelia express a mu opiate receptor. Progress in Neurobiology, 2000, vol. 60, pp. 531–544.
20. Sasaki N., Sato T., Ohler A. E. Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation, 2000, vol. 101, no. 4, pp. 439–445.
21. Lishmanov Y. B., Maslov L. N. Opiatergicheskaya regulation of central hemodynamics. Pathologist Physiology and Experimental Therapy, 2003, no. 1, pp. 2–11 (in Russian).
22. Xiao R. P., Pepe S., Spurgeon H. A. Opioid peptide receptor stimulation reverses b-adrenergic effects in rat heart cells. Am. J. Physiol., 1997, vol. 272, pp. 797–805.
23. Clo C., Muscari C., Tantini B. Reduced mechanical activity of perfused rat heart follwoing morphine or enkephalin peptides administration. Life Sci., 1985, vol. 37, pp. 1327–1333.
24. Maslov L. N., Barzakh E. I. Krylatov A. V. Opioid peptide deltorphin 2 mimics the cardioprotective effect of ischemic preconditioning: the role of delta-2-opioid receptors , protein kinase C, KATF channels. Bul. Exper. Biology and Medicine, 2010, vol. 149, no. 3, pp. 524–543 (in Russian).
25. Rubaj A., Gustaw K., Zgodzinski W., Kleinrok Z., Sieklucka-Dziuba M. The role of opioid receptors in hypoxic preconditioning against seizures in brain. Pharmacol., Biochem. Behavior., 2000, vol. 67. P. 65–70.
26. Vlasova I. G., Torshin V. I. Antihypoxic properties of opiates and substance P. Pathological Physiology and Experimental Therapy, 2001, pp. 13–15 (in Russian).
27. Zabornyj T., Gonzales G. F., Valdez L. B. Mitochondrial contribution to the molecular mechanism of heart acclimatization to chronic hypoxia: role of nitric oxide. Frontiers in Bioscience, 2007, vol.. 12, no. 1, pp. 1247–1259.
28. Lishmanov Y. B., Uskina E. V., Maslov L. N. Opiatergicheskie mechanisms antiarrhythmic effect of adaptation. Bul. Exper. Biology and Medicine, 1996, no. 9. pp. 276–278 (in Russian).
29. Xue-Quin Chen, Ji-Zeng Du Hypoxia infl uenses enkephalin release in rats. Neuropsyiology, 2000, vol. 11, no. 7, pp. 1555–1557.
30. Lishmanov Y. B., Maslov L. N., Tam S.V., Bogomaz S.A. Opioid system and resistance to damage during cardiac ischemia-reperfusion. Rus. Physiol. Journal, 2000, vol. 86, no. 2, pp. 164–173 (in Russian).
31. Endoh Hiroshi, Taga Kichiro, Yamakura Tomohiro. Effects of naloxone and morphine on acute hypoxic survival in mice. Crit. Care Med., 1999, vol 27, no. 9, pp. 1929–1933.
32. Meng Fanjun, Li Junfa, Zhang Bingxi, Ji Fang. nPKCµ and NMDA receptors participate in neuroprotection induced by morphine pretreatment. J. Neurosurg. Anestesiol., 2006, vol. 18, no. 2, pp. 119–124.
33. Zoloyev G. K., Argintaev E. S., Bobrova I. V. Value of mu and delta opioid receptors in the effects of enkephalins to action hypoxic hypoxia. Bul. Exper. Biology and Medicine, 1992, vol. 114, no. 11, pp. 500–502 (in Russian).
34. Kimberly P. Maifi eld, Louis G. D. Role of endogenous opioid peptides in the acute adaptation to hypoxia. Brain. Res., 1992, vol. 582, pp. 226–231.
( 460.04 kB ) 
( 451.12 kB )
Issue: 12, 2013
Series of issue: Issue 12
Rubric: THEORY AND METHODS OF PHYSICAL TRAINING AND SPORTS
Pages: 215 — 221
Downloads: 1614